First Time Loading...

Kintor Pharmaceutical Ltd
HKEX:9939

Watchlist Manager
Kintor Pharmaceutical Ltd Logo
Kintor Pharmaceutical Ltd
HKEX:9939
Watchlist
Price: 1.21 HKD 14.15% Market Closed
Updated: May 5, 2024

Kintor Pharmaceutical Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kintor Pharmaceutical Ltd
Net Income (Common) Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Kintor Pharmaceutical Ltd
HKEX:9939
Net Income (Common)
-¥1.1B
CAGR 3-Years
-28%
CAGR 5-Years
-58%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Net Income (Common)
-¥13.6B
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Net Income (Common)
-¥1B
CAGR 3-Years
-1%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Net Income (Common)
¥1.2B
CAGR 3-Years
23%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Net Income (Common)
¥8.5B
CAGR 3-Years
40%
CAGR 5-Years
47%
CAGR 10-Years
45%
Imeik Technology Development Co Ltd
SZSE:300896
Net Income (Common)
¥1.3B
CAGR 3-Years
61%
CAGR 5-Years
73%
CAGR 10-Years
N/A

See Also

What is Kintor Pharmaceutical Ltd's Net Income (Common)?
Net Income (Common)
-1.1B CNY

Based on the financial report for Dec 31, 2023, Kintor Pharmaceutical Ltd's Net Income (Common) amounts to -1.1B CNY.

What is Kintor Pharmaceutical Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-58%

Over the last year, the Net Income (Common) growth was -11%. The average annual Net Income (Common) growth rates for Kintor Pharmaceutical Ltd have been -28% over the past three years , -58% over the past five years .